Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Donaldson

Showing results (421-430 of 436) with videos related to

Pageof 44
Sort By:
The Journal of Experimental Medicine|March 19, 2003
Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune responseMonica G Chiaramonte, Margaret Mentink-Kane, Bruce A Jacobson, et al.
The Journal of Experimental Medicine|March 19, 2003
Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2Nancy Wood, Matthew J Whitters, Bruce A Jacobson, et al.
The Journal of Experimental Medicine|December 6, 2003
Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrenceMasaki Terabe, So Matsui, Jong-Myun Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2001
IL-13-mediated worm expulsion is B7 independent and IFN-gamma sensitiveJ Urban, H Fang, Q Liu, et al.
American Journal of Respiratory Cell and Molecular Biology|October 7, 2006
Efficacy of IL-13 neutralization in a sheep model of experimental asthmaMarion T Kasaian, Debra D Donaldson, Lioudmila Tchistiakova, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 19, 2024
Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary diseaseLydia J Finney, Peter Fenwick, Samuel V Kemp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvantChristian Taube, Xudong Wei, Christina H Swasey, et al.
Elife|April 13, 2022
Protection of nascent DNA at stalled replication forks is mediated by phosphorylation of RIF1 intrinsically disordered regionSandhya Balasubramanian, Matteo Andreani, Júlia Goncalves Andrade, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2004
RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tractDavid Artis, Mei Lun Wang, Sue A Keilbaugh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2003
IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasisMargaret M Mentink-Kane, Allen W Cheever, Robert W Thompson, et al.
Pageof 44

Showing results (421-430 of 436) with videos related to

Sort By:
Pageof 44
The Journal of Experimental Medicine|March 19, 2003
Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune responseMonica G Chiaramonte, Margaret Mentink-Kane, Bruce A Jacobson, et al.
The Journal of Experimental Medicine|March 19, 2003
Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2Nancy Wood, Matthew J Whitters, Bruce A Jacobson, et al.
The Journal of Experimental Medicine|December 6, 2003
Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrenceMasaki Terabe, So Matsui, Jong-Myun Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2001
IL-13-mediated worm expulsion is B7 independent and IFN-gamma sensitiveJ Urban, H Fang, Q Liu, et al.
American Journal of Respiratory Cell and Molecular Biology|October 7, 2006
Efficacy of IL-13 neutralization in a sheep model of experimental asthmaMarion T Kasaian, Debra D Donaldson, Lioudmila Tchistiakova, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 19, 2024
Impaired antiviral immunity in frequent exacerbators of chronic obstructive pulmonary diseaseLydia J Finney, Peter Fenwick, Samuel V Kemp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvantChristian Taube, Xudong Wei, Christina H Swasey, et al.
Elife|April 13, 2022
Protection of nascent DNA at stalled replication forks is mediated by phosphorylation of RIF1 intrinsically disordered regionSandhya Balasubramanian, Matteo Andreani, Júlia Goncalves Andrade, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2004
RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tractDavid Artis, Mei Lun Wang, Sue A Keilbaugh, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2003
IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasisMargaret M Mentink-Kane, Allen W Cheever, Robert W Thompson, et al.
Pageof 44